Brief: Cytodyn Highlights Nih Grant For Hiv Functional Cure Preclinical Study Of Gene Therapy Based On Leronlimab
11/07/2022 13:44
July 11 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN HIGHLIGHTS NIH GRANT FOR HIV FUNCTIONAL CURE
PRECLINICAL
STUDY OF GENE THERAPY BASED ON LERONLIMAB
Source text for Eikon: ID:nGNX5DbgTm
Further company coverage: CYDY.PK
((reuters.briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer